ArticleResearch square2026
Self-collected dried blood spots for phosphatidylethanol assessment in virtual trials: Feasibility and concordance with self-reported alcohol use among men at high HIV risk.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Background: Phosphatidylethanol (PEth), a phospholipid obtained from whole blood, offers superior sensitivity and detection windows over other biomarkers of alcohol use, and because it can be assayed from dried blood spots (DBS), it can be a suitable biomaker for virtual clinical trials. This study tested the feasibility of utilizing self-collected DBS to obtain PEth among men who have sex with men (MSM) in two virtual trials and examined associations between PEth and self-reported alcohol use. Methods: Participants with hazardous drinking were included from Ending the HIV Epidemic (EHE) jurisdictions in the US South and mid-Atlantic who enrolled in two virtual trials from 2021-2024. One trial focused on MSM who were taking HIV pre-exposure prophylaxis (PrEP), and the other was focused on MSM who were not. PEth was analyzed in DBS, and online surveys collected Timeline Follow-back (TLFB) and AUDIT-C data at baseline, three, and six months. Mixed-effects models evaluated predictors of DBS return rates. Spearman rank correlations assessed associations between PEth and self-reported alcohol use, and mixed-effects models examined moderators of this association. Results: A total of N=339 MSM were provided DBS collection kits. DBS return rates were 94% at baseline, declining to approximately 71-73% at follow-up. Fewer than 1% of samples were rejected for quality-related reasons. Agreement between PEth and self-report in classifying hazardous drinking across baseline and follow-ups was modest overall (62-66%). Spearman correlations were stronger for PEth and AUDIT-C ( Conclusions: Self-collection of DBS for PEth analysis is feasible in virtual trials, although completion at follow-up remains challenging. Findings also suggested that brief self-report measures like the AUDIT-C may be the most practical complement to PEth in virtual alcohol research. Biomarkers should be incorporated into assessments of alcohol use in PrEP research, given that reliance on self-report measures may underestimate alcohol use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.